NCT05307250Active, not recruiting
M-Suubi: A Multi-Level Integrated Intervention to Reduce the Impact of HIV Stigma
M-Suubi: A Multi-Level Integrated Intervention to Reduce the Impact of HIV Stigma on HIV Treatment Outcomes Among Adolescents Living With HIV in Uganda
Source: ClinicalTrials.gov · Last updated 14 Aug 2025
Brief summary (registry, in English)
M-Suubi, a three arm cluster randomized study will examine the effects and cost-effectiveness of a multi-level intervention on HIV viral suppression among 840 adolescents living with HIV (ALHIV) enrolled in 42 secondary schools with a boarding section. The investigators will test the effects of a group-based HIV stigma reduction intervention for educators (GED-HIVSR), over and above the effects of multiple family groups with HIV stigma reduction combined with family economic empowerment (MFG-HIVSR plus FEE), relative to Bolstered Standard of Care (BSOC). ALHIV will be randomized at the school level to one of three study arms
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 1851 (actual)
- First submitted
- 21 Dec 2021
- Start date
- 15 Mar 2022
- Primary completion date
- 31 Jul 2026
- Lead sponsor
- Washington University School of Medicine
- Diseases
- HIV
- NCT number
- NCT05307250
What you commit to
- Study type: Interventional
- Participants enrolled: 1851
- From 15 Mar 2022 to the primary completion date, 31 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- \- A significant cognitive impairment that interferes with the participant's understanding of the informed consent process, or inability/unwillingness to commit to completing the study
Who the study is looking for
- HIV-positive adolescents confirmed by medical report
- Prescribed antiretroviral therapy
- Enrolled in primary and secondary schools in a boarding section
- Caregivers of ALHIV who agree to participate in the study
- Teachers, school nurses, and administrators in the target schools who agree to participate in the study
Age in the registry: 10 years to 17 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| International Center for Child Health and Development Field Office Coordinator of this site? Confirm its status | Masaka | Uganda | Unknown status |
Related publications
- Stigma, Mental Health, and HIV Adherence: A Cross-sectional Structural Equation Modeling Study Exploring Direct and Indirect Effects Among School-Engaged Ugandan Adolescents Living With HIV.J Assoc Nurses AIDS Care · 2026 · PMID 42080911
- HIV-related stigma and academic outcomes: the mediating role of mental health among adolescents living with HIV in Uganda.AIDS Care · 2026 · PMID 41457981
This page is information, not medical advice. Discuss any trial with your doctor.